Royal Bank Of Canada Pliant Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 112,517 shares of PLRX stock, worth $342,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,517

Previous 105,570 6.58%

Holding current value

$342,051

Previous $1.18 Million 25.19%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.55 - $15.7 $73,290 - $109,067	6,947 Added 6.58%	112,517 $1.48 Million
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $563,135 - $768,155	53,530 Added 102.86%	105,570 $1.18 Million
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $50,085 - $73,897	4,734 Added 10.01%	52,040 $559,000
Q1 2024 Nov 05, 2024	SELL	$14.14 - $19.59 $66,938 - $92,739	-4,734 Reduced 9.1%	47,306 $704,000
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $262,735 - $364,001	-18,581 Reduced 28.2%	47,306 $704,000
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $172,652 - $257,299	13,436 Added 25.62%	65,887 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $191,799 - $265,073	13,155 Added 33.48%	52,451 $909,000
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $386,481 - $651,814	-21,329 Reduced 35.18%	39,296 $712,000
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $720,468 - $1.39 Million	38,466 Added 173.59%	60,625 $1.61 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $39,763 - $59,480	2,339 Added 11.8%	22,159 $428,000
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $149,956 - $473,720	19,551 Added 7268.03%	19,820 $415,000
Q2 2022 Aug 15, 2022	SELL	$4.11 - $8.75 $5,737 - $12,215	-1,396 Reduced 83.84%	269 $2,000
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $25,446 - $51,183	-3,630 Reduced 68.56%	1,665 $11,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $35,644 - $53,045	2,905 Added 121.55%	5,295 $71,000
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $12,244 - $21,532	743 Added 45.11%	2,390 $40,000
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $46,198 - $62,075	1,647 New	1,647 $48,000

Others Institutions Holding PLRX

# of Institutions

174

Shares Held

64.8M

Call Options Held

228K

Put Options Held

772K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $148M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Pliant Therapeutics, Inc. Transaction History